The TP53 suppressor gene, a regulator of genome stability and consequently a manipulator of DNA degradation, is mutant in 40–70% of HNSCC and thus inactivates the product or protein with effect on the cell cycle. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.